Adverse events and complications · women undergoing outpatient hysteroscopy
Saline probably leads to lower adverse events and complications compared with carbon dioxide (moderate certainty).
1 finding from 1 review
Quality of hysteroscopic view · women undergoing outpatient hysteroscopy
Saline may leads to lower quality of hysteroscopic view compared with carbon dioxide (low certainty).
1 finding from 1 review
Duration of the procedureassessed in seconds · women undergoing outpatient hysteroscopy
1 finding from 1 review
Tolerability of the procedure · women undergoing outpatient hysteroscopy
1 finding from 1 review
Adverse events and complications · women undergoing outpatient hysteroscopy
1 finding from 1 review
Quality of hysteroscopic view · women undergoing outpatient hysteroscopy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of the procedureassessed in seconds · women undergoing outpatient hysteroscopy
1 finding from 1 review
Bruise size 48 hours after injection (mm/mm2) · patients treated with subcutaneous heparin injections
1 finding from 1 review
Bruise size ‐ 60 hours after injection (mm2) · patients treated with subcutaneous heparin injections
1 finding from 1 review
Bruise size ‐ 72 hours after injection (mm2) · patients treated with subcutaneous heparin injections
1 finding from 1 review
Bruise incidence ‐ 48 hours after injection · patients treated with subcutaneous heparin injections
Slow may leads to lower bruise incidence ‐ 48 hours after injection compared with fast subcutaneous heparin injection (low certainty).
2 findings from 1 review
Urinary protein or albumin excretion ‐ total albumin excretion at 6 months · People with proteinuria or microalbuminuria due to sickle cell disease
1 finding from 1 review
Creatinine level · People with proteinuria or microalbuminuria due to sickle cell disease
1 finding from 1 review
Electrolyte levels · People with proteinuria or microalbuminuria due to sickle cell disease
1 finding from 1 review
Blood pressure · People with proteinuria or microalbuminuria due to sickle cell disease
1 finding from 1 review
Hemoglobin concentration (g/dL) · People with proteinuria or microalbuminuria due to sickle cell disease
1 finding from 1 review
Adverse events or toxicity · People with proteinuria or microalbuminuria due to sickle cell disease
1 finding from 1 review
Treatment failure (escalation of respiratory therapy to NIV, NIPPV or invasive ventilation) Measured up to 28 days · adults in the ICU, requiring respiratory support
HFNC may leads to lower treatment failure (escalation of respiratory therapy to NIV, NIPPV… compared with standard oxygen therapy (low certainty).
1 finding from 1 review
Adverse events ‐ pneumonia · adults in the ICU, requiring respiratory support
It is very uncertain whether HFNC changes adverse events Respiratory infection (pneumonia) compared with NIPPV or NIV (very low certainty).
1 finding from 1 review
Barotrauma (pneumothorax) · adults in the ICU, requiring respiratory support
HFNC showed no clear difference in barotrauma (pneumothorax) compared with NIPPV or NIV (low certainty).
1 finding from 1 review